Understanding the impact of Biological Reference materials for MHRA
Details
- Supplier(s)
- OHE CONSULTING LIMITED
- Value
- £99,400
- Duration
- 2 months
- Topic
- Economic impact assessment
- Published
- 9 June 2026
- Source
- uk:find_a_tender
Tender description
The Medicines and Healthcare products Regulatory Agency (MHRA) requires support in conducting an economic impact evaluation of its activities related to biological reference materials. A comprehensive value and economic impact assessment will inform and strengthen the business case for investing in a new facility. The Supplier will conduct an economic impact assessment from a societal perspective, capturing the broader value generated for the economy and society at large; It will cover the monetised economic impact assessment and describe benefits that cannot be monetised qualitatively. The analysis will follow HM Treasury Green Book methodology to assess the return on investment and will support the development of a robust business case. The final Deliverable shall be in the form of a fully referenced write up of the economic analysis and will be designed for integration into MHRA documentation and business case. ## Contract award
Timeline
- Completed: Award published9 June 2026Current notice
- Completed: Award date9 June 2026
- Completed: Contract expiry date21 August 2026
About the buyer
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components, buying as a central healthcare organisation with its own commercial team. Contracts Finder carries every live and forthcoming procurement opportunity. Larger competitions move to Find a Tender once they pass the high-value threshold. Suppliers register on the agency's eTendering portal with a DUNS number. A rolling commercial pipeline lists larger opportunities due over the next 18 months.
UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.
Over the past 5 years, most of Medicines and Healthcare products Regulatory Agency's contract awards have been in business services, IT services and laboratory and precision equipment.
Relevant CPV codes
- 79311410 · Economic impact assessment
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov |
7 similar open tenders
See more open tenders related to Understanding the impact of Biological Reference materials for MHRA.
- Open tender
Consultancy and Professional Services
- Open tender
Full Business Case Consultancy Services
Related topics
Topics related to Understanding the impact of Biological Reference materials for MHRA, ranked by notice volume.
- 1,202£4.3bn
- 4,077£20.4bn
- 2,620£5.9bn
Related buyers
Buyers similar to Medicines and Healthcare products Regulatory Agency.
- 3,061£1.8bn
- 1,865£208.9bn
- 1,183£28.7bn
- 799£8.9bn
- 553£22.8bn
- 477£3.8bn
- 432£24.8m
- 370£408.9m
- 307£337.4m
- 295£1.7bn
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
